5-bromo-3-chloro-8-methoxyisoquinoline, 5g

2-Methyl-1-oxo-1,2-dihydroisoquinoline-5-carbonitrile, 97%, 250mg

2-Benzyl-2h-1,2,3,4-tetrazol-5-amine, 95%, 100mg

3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-5-(4-fluorophenyl)-1,4-dihydro-4-oxo-, 99%, 50mg

Nonanal>95.0%(GC)25mL

(R)-Pyrrolidine-2-carbonitrile hydrochloride, 95.0%, 250mg

3-(5-Methyl-2-thienyl)-2-propenoic acid, 98%, 1g

2-Morpholin-4-yl-benzoic acid ethyl ester, 95.0%, 500mg

N-Iodosuccinimide, 98.0%, 100g

1,5-Dichloro-2,4-difluorobenzene, 95.0%, 1g

4-Bromo-3,5-difluorobenzaldehyde, 97.0%, 10g

5-Bromo-2-(dibromomethyl)pyrimidine, 95.0%, 250mg

(2-(Trifluoromethyl)pyrimidin-5-yl)boronic acid, 95.0%, 5g